Deka Research and Development: FDA filings under this applicant name
FDA lists 29 510(k) clearances under 5 spellings of the applicant name “Deka Research and Development” (first 1984, latest 2026), across 11 product codes in 4 review panels. Median 510(k) review time under this name: 99 days. Since 2017 the median was 94 days, against 202 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 1 | 169 |
| 2014 | 0 | — |
| 2015 | 1 | 123 |
| 2016 | 1 | 278 |
| 2017 | 0 | — |
| 2018 | 1 | 184 |
| 2019 | 1 | 94 |
| 2020 | 2 | 194 |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 1 | 627 |
| 2024 | 9 | 89 |
| 2025 | 4 | 122 |
| 2026 | 3 | 27 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Deka Research and Development took a median 94 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 202 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LDR | Controller, Infusion, Intravascular, Electronic | 5 | 5 |
| QFG | Alternate Controller Enabled Insulin Infusion Pump | 5 | 5 |
| QJY | Infusion Pump, Drug Specific, Pharmacy-Filled | 4 | 4 |
| FKX | System, Peritoneal, Automatic Delivery | 3 | 3 |
| FPA | Set, Administration, Intravascular | 3 | 3 |
| FRN | Pump, Infusion | 3 | 3 |
| QJI | Interoperable Automated Glycemic Controller | 2 | 2 |
| FIG | Clamp, Tubing, Blood, Automatic | 1 | 1 |
| IMK | Wheelchair, Stair Climbing | 1 | 1 |
| KDI | Dialyzer, High Permeability With Or Without Sealed Dialysate System | 1 | 1 |
Plus 1 more product codes.
Review panels
Most recent Deka Research and Development 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K262576 | twiist Loop Algorithm | QJI | 2026-10-15 | 80 |
| K261672 | twiist Automated Insulin Delivery (AID) System | QFG | 2026-06-17 | 27 |
| K261530 | iiSure Infusion Set | FPA | 2026-06-03 | 26 |
| K243841 | Sparta Infusion Set for Insulin | FPA | 2025-08-01 | 231 |
| K250930 | twiist system | QFG | 2025-04-02 | 5 |
| K250357 | RemunityPRO Pump for Remodulin® (treprostinil) Injection | FRN | 2025-03-11 | 32 |
| K241736 | Remunity 2.0 Pump for Remodulin (treprostinil) Injection | FRN | 2025-01-16 | 213 |
| K243354 | Remunity System | QJY | 2024-11-27 | 29 |
| K242693 | DEKA Infusion System, DEKA Administration Set | LDR | 2024-10-07 | 28 |
| K240920 | HemoCare Bicarbonate Concentrate Set (BCS) | KPO | 2024-07-12 | 99 |
19 earlier clearances. See the full list in Caduvo.
Recalls
FDA recall records list no recalls under a recalling firm named Deka Research and Development.
9 product recalls in 7 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 1 initiated in the last five years. Most often: Baxter Healthcare Corporation (4), BAXTER HEALTHCARE CORPORATION (2), Baxter Healthcare Corp. (2).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Deka Research and Development is the lead sponsor of 4 device studies on ClinicalTrials.gov (1 active or recruiting). Most recent:
- NCT07356089: Twiist Postmarket Surveillance Study for Type 1 Diabetes (Recruiting, started 2025-12-09)
- NCT06853990: Innovative Automated Insulin Delivery System for Type 2 Diabetes (Completed, started 2025-04-14)
- NCT04198012: An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System (Completed, started 2019-12-16)
- NCT04087213: Study of HemoCare™ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD (Completed, started 2019-09-05)
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Deka Research and Development (a text match, not an official crosswalk):
- A4220 — Refill kit for implantable infusion pump (via FRN)
- E0786 — Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter) (via FRN)
- E0785 — Implantable intraspinal (epidural/intrathecal) catheter used with implantable infusion pump, replacement (via FRN)
FDA spellings included
FDA records this applicant under 5 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Deka Research and Development (13)
- Deka Research & Development Corp. (10)
- DEKA Research & Development (3)
- Deka Research and Development Corp. (2)
- Deka Research and Development Corporation (1)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Deka R&D Corp (1 510(k)s)
- Deka Integrated Solutions Corporation (0 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Deka Research and Development?
FDA lists 29 510(k) clearances under 5 spellings of the applicant name “Deka Research and Development” (first 1984, latest 2026), across 11 product codes in 4 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Deka Research and Development?
The median time from FDA receipt to decision across 510(k)s cleared under the name Deka Research and Development is 99 days. Since 2017: 94 days, versus 202 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Deka Research and Development?
The most frequent FDA product codes under this applicant name are LDR (Controller, Infusion, Intravascular, Electronic, 5); QFG (Alternate Controller Enabled Insulin Infusion Pump, 5); QJY (Infusion Pump, Drug Specific, Pharmacy-Filled, 4).
Next steps
- See all 29 Deka Research and Development clearances with predicates and recalls
- Run predicate analysis for product code LDR, Deka Research and Development's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.